U.S. FDA approves Lexicon Pharma’s drug for heart failure
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration (FDA) has approved…
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration (FDA) has approved…
By Arathy Somasekhar HOUSTON (Reuters) -Oil prices ticked up on Friday as U.S. officials…
By Rachael Levy, Marisa Taylor and Akriti Sharma (Reuters) -Elon Musk's Neuralink…
By Lucia Mutikani WASHINGTON (Reuters) - U.S. consumer spending increased more than…
By David Randall NEW YORK (Reuters) - A last-minute deal to raise the U.S. $31.4 trillion…
By Shivansh Tiwary and David Shepardson (Reuters) -Ford Motor Co shares jumped by more…
By Jaiveer Shekhawat and Echo Wang (Reuters) -Atmus Filtration Technologies Inc, the…
US Mutual Funds Underperform on Shunning Tech Stocks US Mutual funds are paying a!-->!-->!-->…
By Mike Scarcella (Reuters) - A U.S. judge on Thursday approved Apple Inc's $50…
By Naomi Rovnick LONDON(Reuters) - Experienced tech investors are hunting for undervalued…
By Martin Coulter and Supantha Mukherjee LONDON/STOCKHOLM (Reuters) -For months, Sam…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.
Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.